Koju Kamoi

Author PubWeight™ 12.67‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Comparison of infliximab versus ciclosporin during the initial 6-month treatment period in Behçet disease. Br J Ophthalmol 2009 1.91
2 Ocular infiltrating CD4+ T cells from patients with Vogt-Koyanagi-Harada disease recognize human melanocyte antigens. Invest Ophthalmol Vis Sci 2006 1.41
3 Detection of Candida and Aspergillus species DNA using broad-range real-time PCR for fungal endophthalmitis. Graefes Arch Clin Exp Ophthalmol 2011 1.30
4 Cytokine profile in aqueous humor and sera of patients with infectious or noninfectious uveitis. Invest Ophthalmol Vis Sci 2006 1.22
5 Immunological homeostasis of the eye. Prog Retin Eye Res 2012 1.00
6 Timing of recurrent uveitis in patients with Behcet's disease receiving infliximab treatment. Br J Ophthalmol 2010 0.87
7 Behçet's disease ocular attack score 24: evaluation of ocular disease activity before and after initiation of infliximab. Jpn J Ophthalmol 2014 0.84
8 Comparison of the ocular characteristics of anterior uveitis caused by herpes simplex virus, varicella-zoster virus, and cytomegalovirus. Jpn J Ophthalmol 2014 0.82
9 Human iris pigment epithelium suppresses activation of bystander T cells via TGFbeta-TGFbeta receptor interaction. Exp Eye Res 2009 0.80
10 [Clinical Survey of Uveitis in Tokyo Medical and Dental University--Comparison between the Periods of 1998-2001 and 2007-2011]. Nippon Ganka Gakkai Zasshi 2015 0.78
11 Clinical course of patients with Behçet's uveitis following discontinuation of infliximab therapy. Jpn J Ophthalmol 2013 0.77
12 [Effects and safety of infliximab administration in refractory uveoretinitis with Behçet's disease]. Nippon Ganka Gakkai Zasshi 2010 0.75
13 Treatment of rheumatoid arthritis with biologics may exacerbate HTLV-1-associated conditions: A case report. Medicine (Baltimore) 2017 0.75
14 Ocular manifestation in myeloid/NK cell precursor acute leukemia: a case report. Diagnosed by flow cytometry and PCR from aqueous humor. Medicine (Baltimore) 2016 0.75